当前位置: 首页 > 期刊 > 《健康必读·下旬刊》 > 2019年第10期
编号:13403275
冠脉造影术前筛查便潜血的临床意义(3)
http://www.100md.com 2019年10月1日 《健康必读·下旬刊》 2019年第10期
     Sawhney MS et.al. Fecal occult blood test inpatients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs. Dig Dis Sci. 2010 Jun; 55(6): 1637-42

    陳剑等,血清尿素氮联合便潜血检测在上消化道出血诊断中的应用价值,实用医技杂志2015年1月第22卷第1期

    Norbert Wild et.al. A Combination of Serum Markers for the Early Detection of Colorectal Cancer. Clin Cancer Res; 16(24); 6111–21, 2010.

    Simone Werner et.al. Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening Setting. Clin Cancer Res; 22(7); 1725–33, 2015.

    Wild N, Andres H, Rollinger W, Krause F, Dilba P, Tacke M, et al. Acombination of serum markers for the early detection of colorectal cancer. Clin Cancer Res 2010; 16:6111–21.

    Karl J, Wild N, Tacke M, Andres H, Garczarek U, Rollinger W, et al.Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers. Clin Gastroenterol Hepatol 2008; 6:1122–8.

    Ken Ikeda, et.al. Immunochemical Fecal Occult Blood Tests Predict Dual Antiplatelet Therapy Discontinuation after Coronary Stenting. Intern Med 53: 375-381, 2014., 百拇医药(张哲 杨越屹 樊泽元)
上一页1 2 3